Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desferal for Hypoxia Reaction in Diabetes
NCT03085771Phase 2Unknown
- Sponsor
- Karolinska University Hospital
- Start
- Jan 2017
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of deferoxamine in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Karolinska University Hospital. Primary endpoint: Endothelial precursor cell count at 24 hours. Status: unknown.
02
Drugs
deferoxamine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03085771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03085771.